• Health
  • Science
  • U.S.
  • Technology
  • Business
  • World
  • Politics
  • Entertainment
  • Sports

Building a Better World

News and information

  • Home
  • Privacy Policy
  • Contact Us
  • Our Team

New Discovery Could Lead to Alzheimer’s Breakthrough

November 29, 2015 By Jerry Newberry

New Discovery Could Lead to Alzheimer’s Breakthrough

Investigation identifies proteins causing loss of connections in the brain.

Alzheimer’s disease is projected to strike more than 14 million Americans by the year 2050, and scientists are racing to find a cure for the dreaded disease that affects the brain.

According to an article on medicalnewstoday.com, a new discovery about the early development of the disease could lead researchers down a path to a cure.

The research team, led by scientists at the University of New South Wales (UNSW) in Australia say they have found how brain cell connections are being destroyed in the early stages of the disease, and that breakthrough could lead to a new type of research.

Alzheimer’s disease was first discovered in 1906, by Dr. Alois Alzheimer after observing the symptoms of a woman who died after experiencing memory loss and unpredictable behavior.  Dr. Alzheimer noted abnormal clumps and tangled fibers in the brain tissue of the woman.

This new study looked at loss of synapses, which connect brain neurons and are required for all brain functions.  The loss occurs very early at the onset of the disease, when only mild cognitive impairment is noted, well before the time the nerve cells begin to die.

Dr. Vladimir Sytnyk, from the UNSW School of Biotechnology and Biomolecular Sciences said he and his colleagues investigated a brain protein called neural cell adhesion molecule 2 (NCAM2), a member of a family of molecules that connect snyapse membranes.  The synapses help maintain the connections between neurons.

Through the study of mice, the research team discovered that NCAM2 was being broken down by beta-amyloid proteins, the abnormal clumps that develop in the brains of Alzheimer’s patients.

Dr. Synthk explained they team had identified a new molecular system that directly contributed to loss of synapses, and they think the discovery can lead to earlier diagnosis and eventually new treatments for the disease.

He added the discovery of the link between the loss of NCAM2 as a result of the toxic effects of beta-amyloid opened a new avenue of research for possible treatments to slow down or prevent the destruction of NCAM2 in a person’s brain.

As of 2013, five million Americans were suffering from Alzheimer’s disease.  Symptoms of the disease typically appear in persons over 60 and the risk of getting the disease increases with age.

The findings of the study were published in the journal Nature Communications.

Sharing

Facebooktwittergoogle_plusredditpinterestlinkedintumblrmail

Filed Under: Front Page, Health

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Follow Us

Facebookrss

Search:

Recent Posts

  • NASA’s InSight spacecraft makes important course correction May 26, 2018
  • Scientists outraged at latest Trump decision May 15, 2018
  • Huge uproar erupts over major incident at Utah park May 13, 2018
  • Incredible moon discovery stuns scientists May 12, 2018
  • Authorities shocked by discovery about common painkiller May 6, 2018
  • Outrageous crocodile experiment stuns scientists May 5, 2018
  • Great Barrier Reef is too quiet, scientists say May 1, 2018
  • Massive Hiroshima bomb discovery shocks scientists May 1, 2018
  • Earth will be slammed by massive asteroid April 29, 2018
  • Teens are doing something incredibly alarming in schools April 29, 2018
  • Huge discovery in Tasmania stuns scientists April 28, 2018
  • Shocking discovery in New Jersey stuns authorities April 22, 2018
  • Huge volcanic explosion could wipe out the United States April 21, 2018
  • Huge controversy erupts over world’s hottest pepper April 15, 2018
  • SpaceX is about to do something astonishing April 15, 2018

Copyright © 2021 Jones Kilmartin Group, LLC · Metro Pro Theme On Genesis Framework · WordPress